EVMN
Evommune, Inc.
6.70$
-3.9%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -69.0% | – | – | – | -796.6% | – | -96.4% | – | – | – | -741.5% | |
| 3.9% | – | – | – | 12.6% | – | 3.1% | – | – | – | 15.4% | |
| – | – | – | – | – | – | 5.6% | – | – | – | 128.1% | |
| -30.8% | – | – | – | -332.1% | – | 24.8% | – | – | – | 88.1% | |
| 1.0% | – | – | – | 0.0% | – | 1.3% | – | – | – | 5.0% | |
| 137.8% | – | – | – | 450.0% | – | -239.1% | – | – | – | -2,008.7% | |
| – | – | – | – | – | – | -1.0% | – | – | – | -4.1% | |
| -0.9% | – | – | – | -5.1% | – | -2.7% | – | – | – | 2,742.2% | |
| 485.6% | – | – | – | 190.1% | – | -350.2% | – | – | – | -20.1% | |
| -70.0% | – | – | – | -796.6% | – | -97.7% | – | – | – | -746.5% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.